Latest Posts › UK

Share:

UK Life Sciences and Healthcare Newsletter - November 2021: Regulatory Updates

Regulatory Updates: Health and Care Bill: medicine information systems  The Health and Care Bill was introduced to the House of Commons on 6 July 2021. Clause 85 of the Bill amends the Medicines and Medical Devices Act 2021...more

UK Life Sciences and Healthcare Newsletter - November 2021: Dechert Healthcare Deals Conference 2021 | Panel Discussion: Private...

Dechert’s Healthcare Deals Conference 2021 was recently held in-person at BMA House in London and streamed live across the globe via a virtual platform. The one-day hybrid conference brought together senior pharma,...more

UK Life Sciences and Healthcare Newsletter - August 2021: Revised FCA Rules for SPAC Listings

On 30 April 2021, the FCA consulted on proposals to change the UK Listing Rules to remove the presumption that the listing of a Special Purpose Acquisition Company (“SPAC”) be suspended when it identifies a potential...more

UK Life Sciences and Healthcare Newsletter - August 2021: RHC Recommendations for the Reform of Medical Devices Regulation

On 19 August 2021, the Regulatory Horizons Council (the “RHC”) published a report setting out recommendations for reforming the regulation of medical devices in the UK (the “Report”). The RHC is an independent expert...more

UK Life Sciences and Healthcare Newsletter - July 2021: Future Fund: Breakthrough

The British Business Bank (“BBB”) has launched a new fund, whereby the BBB (which is backed by the UK government), will co-invest with certain investors in high-growth, innovative firms. It is called Future Fund: Breakthrough...more

Life Sciences Sector Vision

On 7 July 2021, the UK government (the “Government”) published the UK Life Sciences Vision (the “Vision”) setting out a 10-year strategy for the UK life sciences sector “to solve some of the biggest healthcare problems of our...more

UK Life Sciences and Healthcare Newsletter - June 2021: Medicinal Cannabis in the UK: Fund Structuring, Investment and Listing...

The value of the global medicinal cannabis market is projected to reach US$62.7 billion by 2024, with over US$22 billion of that market generated by Europe and an estimated excess of £2 billion likely to be generated in the...more

UK Life Sciences and Healthcare Newsletter - June 2021: A New Era for International Data Transfers: European Commission Adopts New...

The European Commission has issued new Standard Contractual Clauses designed to facilitate international transfers of personal data in compliance with the GDPR. The new provisions better reflect the variety of global data...more

UK Life Sciences and Healthcare Newsletter - May 2021: Equity Incentives: Single and Double Trigger Vesting

Share options or other equity incentives (such as growth shares) are an effective way to align the interests of investors with those individuals managing the company on a day-to-day basis. As a result, they are a common...more

UK Life Sciences and Healthcare Newsletter - May 2021: COVID-19 Collaborations and EU Competition Law Compliance

The European Commission’s antitrust arm, DG COMP, has for the second time publicly confirmed that a COVID-19 initiative among pharmaceutical companies is compliant with EU antitrust laws. It did so by way of a “comfort...more

UK Life Sciences and Healthcare Newsletter - March 2021: Granting Incentives Under U.S. Plans to UK-based Executives

One of the most effective ways to incentivise staff, in particular senior employees, is to offer them the opportunity to purchase stock or shares in a group company. U.S. companies often operate stock and other incentive...more

UK Life Sciences and Healthcare Newsletter - March 2021: Future Fund: Breakthrough

Following the successful run of the government-backed Future Fund, the British Business Bank has announced that it is set to launch a further fund for development, Future Fund: Breakthrough. This scheme is set to provide up...more

UK Life Sciences and Healthcare Newsletter - February 2021: Market News

Other recent notable industry transactions: Thermo Fisher Scientific Inc. completed the acquisition of Henogen SA, Novasep's viral vector manufacturing business in Belgium for approximately €725 million in cash....more

UK Life Sciences and Healthcare Newsletter - February 2021: Regulatory Updates

The National Institute for Health and Care Excellence public consultation - The National Institute for Health and Care Excellence (“NICE”) has commenced a public consultation on its technology evaluation process when...more

UK Life Sciences and Healthcare Newsletter: Market News

Recent notable industry transactions. Royal Philips announced that it has agreed to acquire Capsule Technologies, Inc., a provider of medical device integration and data technologies for hospitals and healthcare...more

UK Life Sciences and Healthcare Newsletter: Regulatory Updates

MHRA updates post-transition guidance Since 31 December 2020, the Medicines and Healthcare products Regulatory Agency (MHRA) has been updating various aspects of the regulatory regime for medicines and medical devices...more

UK Life Sciences and Healthcare Newsletter - December 2020: Market News

Recent notable industry transactions. The Alan Turing Institute, the Royal Statistical Society and the UK Department of Health and Social Care's Joint Biosecurity Centre finalised a partnership agreement in relation to the...more

UK Life Sciences and Healthcare Newsletter- December 2020: Regulatory Updates

Medicines and Medical Devices Bill (MMDB) – The MMDB is intended to act as the primary UK legislation specifying powers that would enable the regulatory regimes for human medicines, clinical trials, veterinary medicines and...more

UK Life Sciences and Healthcare Newsletter - December 2020: A Brief Update on the EMI Scheme

As the most tax advantageous HMRC approved share option scheme available, the Enterprise Management Incentive (EMI) scheme has long been the preferred form of incentive for eligible early and mid-stage UK-based life science...more

UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill

The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and...more

20 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide